← Pleural Disease

Don't discard the supernatant: pleural fluid cfDNA for molecular profiling in lung cancer.


Pleural fluid supernatant cfDNA should be routinely preserved and can already be used selectively for molecular profiling in NSCLC, while broader implementation requires prospective clinical validation.
Read the full paper ↗

Keep reading

N opens the next one